Plné znění - 2/2008 Sb. m. s.

Xxxxxxxxxxxx zahraničních xxxx xxxxxxx, xx xxx 16. xxxxxxxxx 2007 bylo xxxxxxxxxx xxxxxxxxx XXXXXX, xxxxxxxxxxx Xxxxxxxxxxx úmluvy xxxxx xxxxxxx ve xxxxxx¹⁾, xxxxxxxx schválení xxxxxx xxxxx Přílohy I - Xxxxxxx xxxxxxxxxx látek x xxxxx dopingu.

Xxxxxxx I xxxxxxxxx x platnost x xxxxxxx s článkem 34 xxxx. 3 Xxxxxx xxx 1. xxxxx 2008 x tímto xxxx xxxxxxxxx v xxxxxxxx i xxx Xxxxxx republiku. Dnem xxxxxx Xxxxxxx X x xxxxxxxx xxxxxxxx xxxxxx Příloha I Xxxxxxxxxxx úmluvy proti xxxxxxx xx xxxxxx xx znění pro xxx 2007, xxxxxxxxx xxx x. 59/2007 Xx. x. x.

Xxxxxxxx xxxxx Xxxxxxx X a xxxx xxxxxxx xx xxxxxxx xxxxxx xx xxxxxxxxx xxxxxxxx.

X1. XXXXXXXXXX LÁTKY

Xxxxxxxxxx xxxxx jsou xxxxxxxx.

1. ANDROGENNÍ XXXXXXXXXX XXXXXXXX (XXX):

x. Xxxxxxxx * XXX, zahrnující:

1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3β,17β-xxxx); 1-androstendion (5α-xxxxxxx-1-xx-3,17-xxxx); xxxxxxxxx (19-xxxxxxxxxxxxxxxx); xxxxxxxxxx; xxxxxxxx; xxxxxxx (androsta-1,4-dien-3,17-dion); xxxxxxx (17α-xxxxxxx-17β-xxxxxxxxxxxxxx-4-xxx[2,3-x]xxxxxxxx); xxxxxxxxxxxxxxxxxxxxxxxxxxxxx (4-xxxxxx-17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxxxxxxxxxxxxxxxx (17α-xxxxx-5α-xxxxxxx-2-xx-17β-xx); xxxxxxxxxxx; ethylestrenol (19-xxx-17α-xxxxx-4-xx-17-xx); xxxxxxxxxxxxxx; formebolon; furazabol (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxxxxx[2,3-x]-xxxxxxx); xxxxxxxxx; 4-hydroxytestosteron (4,17β-xxxxxxxxxxxxxxxx-4-xx-3-xx); xxxxxxxxxx; klostebol; xxxxxxxxxx; xxxxxxxxxx; metandienon (17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); metenolom; methandriol; xxxxxxxxxx (2α, 17α-xxxxxxx-5α-xxxxxxxxx-3-xx-17β-xx); xxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxx-4,9-xxxx-3-xx); methyl-1-testosteron (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxx-1-xx-3-xx); xxxxxxxxxxxxxxxxxxxx (17β-hydroxy-17α-metylestr-4-en-3-on); xxxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxx-4,9,11-xxxxx-3-xx); xxxxxxxxxxxxxxxxx; xxxxxxxxx; xxxxxxxxx; 19-xxxxxxxxxxxxxxxx (xxxx-4-xx-3,17-xxxx); xxxxxxxxxx; xxxxxxxxxxxxxx; xxxxxxxxxxxx; oxabolon; xxxxxxxxxx; xxxxxxxxxxx; oxymetolon; prostanozol ([3,2-x]xxxxxxx-5α-xxxxxxxxxxxxxx-17β-xxxxxxxxxxxxxxxxx); quinbolon; xxxxxxxxxx; xxxxxxxxx; 1-testosteron (17β-xxxxxxx-5α-xxxxxxx-1-xx-3-xx); xxxxxxxxxxxxxxxxxxx (18α-xxxx-xxxxxx-4,9,11-xxxxx-17β-xx-3-xx); xxxxxxxxx x xxxxx xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx podobnými xxxxxxxxxxxx xxxxxx.

x. Xxxxxxxxx ** XXX:

Xxxxxxxxxxxxx (androst-5-en-3β,17β-diol), androstendion (xxxxxxx-4-xx-3,17-xxxx), xxxxxxxxxxxxxxxxxx, xxxxxxxxx (xxxxxxxxxxxxxxxxxxxxx, DHEA), xxxxxxxxxxx x následující xxxxxxxxxx x isomery:

5α-xxxxxxxxx-3α,17α-xxxx xxxxxxx-5-xx-3β,17α-xxxx

5α-xxxxxxxxx-3α,17β-xxxx 4-xxxxxxxxxxxxx (androst-4-en-3β,17β-diol)

5α-xxxxxxxxx-3β,17α-xxxx 5-xxxxxxxxxxxxx (xxxxxxx-5-xx-3,17-xxxx)

5α-androstan-3β,17β-diol epi-dihydrotestosteron

xxxxxxx-4-xx-3α,17α-xxxx 3α-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-4-xx-3α,17β-xxxx 3β-xxxxxxx-5αxxxxxxxxx-17-xx

androst-5-en-3β,17α-diol 19-norandrosteron

xxxxxxx-5-xx-3α,17α-xxxx 19-xxxxxxxxxxxxxxxxx

xxxxxxx-5-xx-3α,17β-xxxx

V xxxxxxxxx, xxx xxxx xxxx produkovat androgenní xxxxxxxxxx steroid xxxxxxxxx, xxxx se mít xx xx, že Xxxxxx obsahuje xxxx Xxxxxxxxx xxxxx x xxxx xxxxxx xxxxxxxxx Xxxxxxxxx laboratorní xxxxx, xxxx xx koncentrace Xxxxxxxx látky xxxx xxxxxx xxxxxxxxxx nebo xxxxxxxxxxx a/nebo xxxx xx jakýkoli xxxx xxxxxxxxx poměr ve Xxxxxx Xxxxxxxxx xxxxxxxx xxxxxxxxx od xxxxxxx xxxxxx, xxxxx se xxxxxxxx xxxxxxxxx x xxxx xxx, xx xxxxxxxxxx xxxxxxxx endogenní xxxxxxxx. Xxxxxx xx xxx xx xx, xx Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx x xxxxxxx xxxxxxx, xxxxx Xxxxxxxxx xxxxxxx, že xx xxxxxxxxxxx Xxxxxxxx xxxxx xxxx jejích xxxxxxxxxx xxxx xxxxxxxxxx x/xxxx příslušný xxxxx xx Xxxxxx Sportovce xxxxxxxx xxxxxxxxxxxxx xxxx xxxxxxxxxxxx xxxxxx.

Xxxx xx xxx za xx, xx Xxxxxx Xxxxxxxxx xxxxxxxx Xxxxxxxxx xxxxx x laboratoř xxxxxxx Xxxxxxxxx laboratorní xxxxx xx xxxxx xxxxxxxxx a xxx xxxxxxxxx koncentraci, xxxxx xxx xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (např. XXXX) xxxxxxxx, xx xx Zakázaná xxxxx xxxxxxxxxx původu. X xxxxxxx případě xxxx xxxxx xxxxxxxx další xxxxxxx.

Xxxx xx xxxxxxx výsledku analýzy xxxxxxxx xxxxxxxxxxx od xxxxxxx hodnot, xxxxx xx xxxxxxxx xxxxxxxxx x xxxx x xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxxxxx xxxxxxxx xxxxx Xxxxxxxx xxxxx, xxx xxxxxxxx xxxxxx xxxxxxx Xxxxxxxx xxxxx, jako xxxx. xxxxxxxxx x xxxxxxxxxxx xxxxxxxxxxxx xxxxxxxxxxx xxxxxxx, xxxx když xxxxxxxxx xxxxxxxxx xxxxx X/X vyšší xxx xxxxx (4) xx xxxxx (1) x xxxxx spolehlivá analytická xxxxxx (např. XXXX) xxxxxxxxxxx exogenní xxxxx xxxxx, provede příslušná Xxxxxxxxxxxxx xxxxxxxxxx xxxxx xxxxxxx xxxxxxxxxx xxxxxxxx xxxxxxxxxx testů xxxx xxxxxxxxxx následných testů.

Xx-xx xxxxxxxxxx xxxxxx xxxxx šetření, pak xxxxxxxx xxxx laboratoří xxxxxx jako neobvyklý x xx jako xxxxxxxxx. Xxxxx xxxxxxxxx xxxxxxx, xx xxxxxxx xxxxxxxxxx analytické xxxxxx (xxxx. IRMS) xxxxxxxx xxxxx Xxxxxxxx xxxxx, xxxx xxxxx xxxxxxxx xxxxx xxxxxxx, x xxxx se xxx xx to, xx Xxxxxx xxxxxxxx Zakázanou xxxxx. Xxxxx xxxxxx xxxxxxx xxxxxxxxxx analytická xxxxxx (např. XXXX) x xxxxxx x xxxxxxxxx xxxxxxxxx 3 xxxxxxxxx xxxxx, xxxx xxxxxxx xxxxxxxxxxxxxx profil Xxxxxxxxx xxx, xx xxxx xxxxxxxxxx Xxxxxxxxxxxxxx xxxxxxxxxx x následujících 3 měsících xxxxxxx xxxxxxxx xxx xxxxxxxxxxx xxxxxxxx. Xxxxxxxx, xxxxx xxxxxxxxxx xxxx xxxxxxxxxxxxxx xxxxxx, xxxx xxxxxx xxxx xxxxxxxxx. Pokud xxxxxxxxxxxxxx xxxxxx Xxxxxxxxx, xxxxxxxx následnými xxxxx, xxxx xxxxxxxxxxxx normální, xxxx se xxx xxxxxxxxx xx Pozitivní xxxxxxxxxxx nález.

X xxxxxxxx xxxxxxxx individuálních xxxxxxxxx xxxx být x xxxx xxxxxx xxxxxxx boldenon xxxxxxxxxxx xxxxxx ve xxxxxx xxxxxx xxxxxxxxxxxxx (xx/xx). Xxxxx laboratoř xxxxxx xxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxxxxx xxxxxxxx xxxxx Xxxxxxxx látky, xxxx xxx provedeno xxxxx xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxx (xxxxxxxxxx xxxxx).

Xxxxx laboratoř nahlásila Xxxxxxxxx laboratorní nález 19-xxxxxxxxxxxxxxx, xxxx xx xx xxxxxxxxx za xxxxxxx x xxxxxxxxxxx xxxxx exogenního původu Xxxxxxxx xxxxx. X xxxxxxx xxxxxxx xxxx xxxxx provádět xxxxx xxxxxxx.

V případě, xx Xxxxxxxxx xxxxxx xxxxxxxxxxxxx xxx xxxxxxx xxxxxxxxx, bude se xxx xx xx, xx Xxxxxx Sportovce xxxxxxxx Xxxxxxxxx látku.

2. Ostatní xxxxxxxxxx xxxxx, xxxxxxxxxx:

Xxxxxxxxxxx, xxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxx (XXXX), xxxxxxx, xxxxxxx, xxxxxxxxxx, ale xx x xxxxxxxx xxxxx na ně.

X2. XXXXXXX X XXXXXXXX XXXXX

Xxxxxxxxxxx xxxxx x xxxxxx uvolňující xxxxxxx xxxx zakázány:

1. Xxxxxxxxxxxx (XXX);

2. Xxxxxxx hormon (xXX), xxxxxxxx xxxxxxx xxxxxxx xxxxxxx (xxxx. XXX-1), xxxxxxxxxx růstové xxxxxxx (MGF);

3. Xxxxxxxxxxxxx (např. LH, xXX), xxxxxxxx jen x xxxx;

4. Xxxxxxxx;

5. Xxxxxxxxxxxxxx

x xxxxx látky x podobnou xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx.

Xxxxx Xxxxxxxxx xxxxxx prokázat, xx xxxxxxxxxxx byla xxxxxxxxx xxxxxxxxxxxxx xx xxxxxxxxxxxx stavem, bude xx mít xx xx, xx Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx (xxx xx xxxxxxx xxxx) x xxxxxxxxx, xxx xxxxxxxxxxx Zakázané xxxxx xxxx xxxxxx xxxxxxxxxx xx indikátorů x/xxxx příslušné xxxxxx xx Vzorku Sportovce xxxxxxx překročí xxxxxxx xxxxxxxx xxxxxxxx x xxxx xxx, xx xxxxxxxxxxxx xxxxxxxx endogenní xxxxxxxx.

Xxxxx laboratoř xxxxxxxxx, xx xxxxx xxxxxxxxxx analytické xxxxxx, xx Xxxxxxxx látka xx xxxxxxxxxx původu, xxxx xx mít xx xx, xx Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx x xxxx xxxxxxx Xxxxxxxxx laboratorní xxxxx.

X3. XXXX-2 AGONISTÉ

Xxxxxxx xxxx-2 xxxxxxxx xxxxxx xxxxxx X- a X-xxxxxxx xxxx xxxxxxxx.

Xxxxxxxx jsou xxxxxxxxxx, xxxxxxxxxx, salmeterol x xxxxxxxxxx, xxx xxxxx xx při xxxxxxxx xxxxx udělení xxxxxxxx xxxxxxxxxxxx výjimky.

X xxxx xxxx xxxxxxx xxxxxxxx xxxxx xxxxxxxxxxxx xxxxxxx, xxxx nález xxxxxxxxxxx (xxxxx xxxx xxxxxxxxxx) xxxxx xxx 1000 xxxxxxxxx x 1 xxxxxxxxx xxxx xxxxxxxxx za Xxxxxxxxx xxxxxxxxxxx nález, xxxxx Xxxxxxxxx neprokáže, xx xxxxxxxxxx výsledek xxx xxxxxxxx xxxxxxxxxxxxx užíváním xxxxxxxxxxx v xxxxxxxx.

S4. XXXXXXXXXXX X XXXXXXXXXX HORMONŮ

Xxxxxxxxxxx xxxxxxx xxxx xxxxxxxx:

1. Xxxxxxxxxx xxxxxxxx, xxxxxxxxxx:

2. Selektivní modulátory xxxxxxxxxxxxx xxxxxxxxx (XXXX), xxxxxxxx:

3. Xxxxxxx antiestrogenní xxxxx xxxxxxxxxx:

4. Xxxxx xxxxxxxxxxxx funkce xxxxxxxxxx xxxxxx xxxxxxxxxx xxxxxxxxxx, xxx xx x omezením xxxxx xx xx.

X5. XXXXXXXXX X XXXXXXX XXXXXXXXX LÁTKY

Maskovací xxxxx xxxx xxxxxxxx. Xxxxxxxx:

Xxxxxxxxx*, xxxxxxxxxxxxxx, probenecid, xxxxxxxxxx xxxx-xxxxxxxxx (xxxx. xxxxxxxxxx, dutasterid), xxxxxxxxxxxxxxx (xxxx. xxxxxxx, dextran, xxxxxxxxxxxxxxxxx) a další xxxxx s xxxxxxxxx xxxxxxxxxxxx účinky.

Xxxxxxxxx xxxxxxxx:

Acetazolamid, xxxxxxxx, xxxxxxxxx, furosemid, chlortalidon, xxxxxxxxx, xxxxxxxx, xxxxxxxx xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxx (např. xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxx, chlorothiazid), xxxxxxxxxx x xxxxx xxxxx x xxxxxxxx chemickou xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx účinky (xxxxx xxxxxxxxxxxx, xxxxx xxxx xxxxxxxx).

* Xxxxxxxxxxxx xxxxxxx xxxx platná, xxxxx moč Xxxxxxxxx xxxxxxxx xxxxxxxxx xx xxxxxxx x xxxxxxxx xxxx xxxxxxxxxxx hladinou xxxx Xxxxxxxx xxxxx (xxxxx).

X1. XXXXXXXXX PŘENOSU XXXXXXX

Xxxxxxxx xx xxxxxxxxxxx:

X2. XXXXXXXX X XXXXXXXXX MANIPULACE

X3. XXXXXX DOPING

Xxxxxxxxxxxxxx xxxxxxx buněk, xxxx, xxxxxxxx xxxxxxxx, xxxx xxxxxxxxxx exprese genů, xxxxx mají schopnost xxxxxx xxxxxxxxx výkon, xx zakázané.

X6. XXXXXXXXXXX

Xxxxxxx xxxxxxxxxxx (xxxxxx xxxx xxxxxx xxxxxxxxxx optických (X- x X-) xxxxxxx) jsou xxxxxxxx, x xxxxxxxx xxxxxxxx xxxxxxxxx x xxxxxxx xxxxxx xxxxxxxx xxxxx x xxxxxxxxxxx zahrnutých xx Monitorovacího xxxxxxxx xxx rok 2008.

Xxxxxxxxxxx zahrnují:

Adrafinil, xxxxxxxxx**, amfepramon, xxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxxxxxx, efedrin****, etamivan, xxxxxxxxx, xxxxxxxxxxxxxx, famprofazon, xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, fenkamfamin, xxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxx, fenproporex, xxxxxxxxx, 4-xxxxxxxxxxxxxx (xxxxxxxx), xxxxxxxxxx, heptaminol, xxxxxxxxxxxx, xxxxx***, xxxxxxxxxxx, kokain, xxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxx, mefentermin, xxxxxxxxxxxx, xxxxxxxxxxxx (X-), xxxxxxxxxxxx****, xxxxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxxxxxxxxx, methylfenidát, xxxxxxxx, modafinil, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxx, oxilofrin, xxxxxxxxxxxxxxxxxxxx, xxxxxxx, xxxxxxxxxxx, x-xxxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxx, selegilin, xxxxxxxxxx, xxxxxxxxx, tuaminoheptan x xxxxx xxxxx x xxxxxxxx chemickou xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx.

Xxxxxxxxxxxx xxxxxxxxx xxxxxxxx xxxx xxxxxxxx x xxxxx xxxxxx bude xxxxxxxxxx xx xxxxxxxxxxx xxxxx xxxxx, pokud Xxxxxxxxx xxxxxxx, xx xxxx všeobecná xxxxxxxxxx x xxxxxxx xxxxxxxxx xxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx, xxxx xx x xxx menší xxxxxxxxxxxxxxx, xx xxxx xxxxxxx xxxxxxxx xxxx xxxxxxxxx xxxxx.

X7. XXXXXXXXX

Xxxxxxxxxxx xxxxxxxxx xxxx xxxxxxxx:

Xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxx(xxxxxx), fentanyl x xxxx xxxxxxxx, xxxxxxxxxxx, metadon, morfin, xxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxx.

X8. XXXXXXXXXXX

Kanabinoidy (xxxx. xxxxx, xxxxxxxxx) xxxx xxxxxxxx.

X9. XXXXXXXXXXXXXXXXXXXX

Všechny glukokortikosteroidy xxxxxxxx xxxxxx, xxxxxxxx, xxxxxxxxxx nebo nitrosvalovou xxxxxxxx xxxx xxxxxxxx. Xxxxxx xxxxx xxxxxxxx xxxxxxxxxxxxx výjimku.

Xxxx xxxxxxx xxxxxxxx xxxxxxxx (xxxxxxxxxxxx, do xxxxx xxxxxx, xx okolí xxxxxx, xxxxxxxxxx, xx xxxx) x xxxxxxxxx xxxxxxxx vyžadují xxxxxxxxx xxxxxxxxxxxxx výjimku x xxxxxxxx níže xxxxxxxxx.

Xxxxxxx přípravky podávané xx xxxxxx xxxxx (xxxxxx xxxxxxxxxxx/xxxxxxxxxx), xxxx, xxxxx, xxxx, potíže xxxxx xxxxxxx xxxxxx, xxxxxxxx xxx a xxxxx xxxxxx xxxxxxxx x xxxxxxxxxx xxxxxx xxxxx xxxxxxxxxxxx výjimky.

P1. XXXXXXX

Xxxxxxx (xxxxxx) xx xxxxxxxx pouze Xxx xxxxxxx x xxxxxxxxxxxxx xxxxxxxx. Detekce xx bude provádět xxxxxxxx xxxxxxxx x/xxxx xxxxxxxx xxxx. Xxxxxxx xxxxxxx pro xxxxxxxx xxxxxxxxxxx xxxxxxxx (xxxxxxxxxxxxx xxxxxxx) xx pro xxxxxx xxxxxxxx xxxxxxx x závorkách.

∙ Xxxxxxxxxxxx sport (FIA) (0.10 x/x)

∙ Xxxxxx (XXX) (0.10 x/x)

∙ Xxxxxxx xxxxxx a parašutismus (XXX) (0.20 x/x)

∙ Xxxxxxxxxxx (XXXX, XXX) (0.10 x/x)

∙ Xxxxxxx pětiboj (XXXX) xxx pro xxxxxxxxxx xx xxxxxxxx (0.10 g/l)

∙ Xxxxxxxxxxx xxxxx (XXX) (0.10 g/l)

∙ Xxxxx motorismus (XXX) (0.30 x/x)

∙ Kuželky (XXX) (0.10 g/l)

X2. BETA-BLOKÁTORY

Pokud xxxx xxxxx xxxxxx, xxxx-xxxxxxxxx jsou zakázány xxxxx Xxx xxxxxxx x následujících xxxxxxxx.

∙ Automobilový xxxxx (XXX)

∙ Billiard (XXXX)

∙ Boby (XXXX)

∙ Xxxxx (XXX)

∙ Xxxxxxx (XXX)

∙ Xxxxxxxxxx (XXX)

∙ Jachting (XXXX) - "match xxxx" - jen xxxxxxxxxxx

∙ Kuželky (XXX)

∙ Xxxxxxx xxxxxx a xxxxxxxxxxxx (XXX)

∙ Lukostřelba (XXXX, XXX) (zakázané xxxx Xxxx soutěž)

∙ Xxxxxxxx (XXX) - xxxxx xx xxxxxx x xxxxxxxxxxx xxxxxxxx-xxxxx x U-rampa, x xxxxxxxxx X-xxxxx x "xxx xxx"

∙ Xxxxxxx xxxxxxx (XXXX) - xxx xxxxxxxxxx xx střelbou

∙ Xxxxxxxxxxx xxxxx (XXX)

∙ Xxxxxxxx x obdobné sporty (XXXX, XXX "xxxxx")

∙ Xxxxxxx (XXXX, XXX) (zakázané také Xxxx xxxxxx)

∙ Xxxxx motorismus (XXX)

∙ Xxxxx (XXXX)

Xxxx-xxxxxxxxx zahrnují následující xxxxx:

Acebutolol, xxxxxxxxxx, xxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxx, celiprolol, xxxxxxx, xxxxxxxxx, xxxxxxxxxx, labetalol, xxxxxxxxxxx, metipranolol, xxxxxxxxxx, xxxxxxx, oxprenolol, pindolol, xxxxxxxxxxx, xxxxxxx, timolol, xxx xx s xxxxxxxx xxxxx xx xx

"Xxxxxxxxxx xxxxx"* xxxx xxxxxxxxxxx xxxx:

∙ Xxxxxxx Beta-2 xxxxxxxx v inhalaci, xxxxx xxxxxxxxxxx (xxxxxxx xxxx xxxxxxxxxxx) při xxxxxxxx xxxxxx xxx 1000 ng/ml xxxx x xxxxxxxxxxxx (zařazen xx xxxxxxx S 1.2 Xxxxxxx xxxxxxxxxx xxxxx);

∙ Xxxxxxxxxx xxxx-xxxxxxxxx, probenecid;

∙ Xxxxx, xxxxxxxxxxx, xxxxxxxxxx, xxxxxxx, xxxxxxxx, famprofazon, xxxxxxxxxxxxx, haptaminol, xxxxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxxxxx, p-metylamfetamin, xxxxxxxxxxxx, xxxxxxxxx, norfenefrin, xxxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxx, sibutramin, xxxxxxxxxxxxx a xxxxxxx xxxxxxx stimulancia xxxxxxxxx xxxxxxxx x xxxxxx X6, xxx která Xxxxxxxxx xxxxxxx, xx xxxxxxx podmínky xxxxxxx x xxxxxx S6;

∙ Kanabinoidy;

∙ Xxxxxxx Xxxxxxxxxxxxxxxxxxxx;

∙ Xxxxxxx;

∙ Xxxxxxx Xxxx-xxxxxxxxx.

*"X Xxxxxxx xxxxx xxx xxxxxxxxxxx xxxxxxxxxx xxxxx, xxxxx xxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx, xxxxxxx xxxx všeobecně xxxxxxxx v xxxxxxx xxxxxxxxx přípravcích, xxxx x nichž je xxxxx pravděpodobnost, xx xxxxx xxxxxxx xxxxxxxx xxxx xxxxxxxxx xxxxxxx." Xxxxxxxx xxxxxxxxxxxxxxx pravidla xxxxxxxxxx xxxxxxxx xxxxx xxxx xxxxxxxx xxxxxxx xxxxxx xx xxxxxxxxxxx, xx "...Xxxxxxxxx může xxxxx prokázat, že Xxxxxxx specifické xxxxx xxxxxx xxxxxxxxx xx xxxxxxx xxxxxxxxxxx xxxxxx...".

Xxxxxx xxxxxxx x. 2/2008 Sb. x. x. nabyl účinnosti xxxx 31.1.2008.

Xxxxxx předpis x. 2/2008 Sb. x. x. xxx xxxxxx xxxxxxx předpisem č. 8/2009 Sb. m. s. x xxxxxxxxx xx 7.2.2009.

Xxxxx xxxxxxxxxxxx právních xxxxx xxxxxx xxxxxxxx xxxxxxxx x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx se xxxx netýká xxxxxxxxx xxxxx shora xxxxxxxxx xxxxxxxx předpisu.